Hepatocellular carcinoma in Sydney South West: Late symptomatic presentation and poor outcome for most

Internal Medicine Journal

Volumn 37, Issue 8, 2007, Pages 516-522

  Gellert, L ^a   Jalaludin, B ^b,c   Levy, M ^a  

^a LIVERPOOL HOSPITAL   (Australia)

^b Epidemiology Unit   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Hepatitis; Hepatocellular carcinoma; Surveillance; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NEW SOUTH WALES; PROGNOSIS;

EID: 34447558577     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01392.x     Document Type: Article

References (30)

1. Tracey EA, Chen W, Sitas F. Cancer in New South Wales: Incidence and Mortality 2003. Sydney:Cancer Institute NSW 2005.
2. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998 28:751 5.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334:693 9.
4. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995 332:1256 61.
5. Colella G, Bottelli R, De Carlis L, Sansalone CV, Rondinara GF, Alberti A et al. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 1998 11:S193 6.
6. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005 42:1208 36.
7. McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F et al. Screening for hepatocellular carcinoma in Alaska native infected with chronic hepatitis B: a 16 year population-based study. Hepatology 2000 32:842 6.
8. Giannini E, Arzani L, Borro P, Botta F, Fasoli A, Risso D et al. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis. Hepatogastroenterology 2000 47:1395 8.
9. Zhang B, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004 130:417 22.
10. Nagasue N, Ogawa Y, Yukaya H, Ohta N, Ito A. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma. Gastroenterology 1985 88:768 72.
11. Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004 77:257 67.
12. Law MG, Roberts SK, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust 2000 173:403 5.
13. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997 350:1142 3.
14. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999 340:745 50.
15. Dyer Z, Peltekian K, van Zanten SV. Review article: the changing epidemiology of hepatocellular carcinoma in Canada. Aliment Pharmacol Ther 2005 22:17 22.
16. Brotodihardjo AE, Tait N, Weltman MD, Liddle C, Little JM, Farrell GC. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes. Med J Aust 1994 161:433 5.
17. Kemp W, Roberts SK. Hepatocellular carcinoma in Australia 1975-2002: change in epidemiology and clinical features. J Gastroenterol Hepatol 2005 20:A70.
18. McCaughan GW, Parsons C, Gallagher ND. Primary hepatocellular carcinoma in Australia: aetiological considerations. Med J Aust 1979 1:304 6.
19. Mohamed R, Desmond P, Suh DJ, Amarapurkar D, Gane E, Guangbi Y et al. Practical difficulties in the management of hepatitis B in the Asia-Pacific region. J Gastroenterol Hepatol 2004 19:958 69.
20. Rusli F, Knight VH, Patella S, Sievert W. Surveillance for hepatocellular carcinoma: effect on tumour size and survival. J Gastroenterol Hepatol 2004 19:A267.
21. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CGC, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000 31:330 35.
22. Trevisani F, De Notariis S, Rapaccini G, Farinati F, Benvegnu L, Zoli M et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002 97:734 44.
23. Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol 2005 20:873 81.
24. Perry JF, McCaughan GW, Charlton BA, Strasser SI. Surgical resection vs. transplantation in the treatment of hepatocellular carcinoma (HCC). J Gastroenterol Hepatol 2004 19:A266.
25. Yang B, Zhang B, Xu Y, Wang W, Shen Y, Zhang A et al. Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol 1997 123:357 60.
26. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001 48:251 9.
27. Poustchi H, George J, Labio ED, Coverdale SA, Carney RG, Perry JF et al. Screening for liver cancer: feasibility of a randomised controlled trial. J Gastroenterol Hepatol 2005 20:A11.
28. Liaw YF, Sung JL, Chow WC, Farrell G, Lee CZ, Yuen H et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004 351:1521 31.
29. Benvegnu L, Chemello L, Noventa F, Fattovich G, Pontisso P, Alberti A. Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis. Cancer 1998 83:901 9.
30. Tanaka K, Sata M, Uchimura Y, Suzuki H, Tanikawa K. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma? Oncol Rep 1998 5:205 8.